The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Lamotrigine extended-release tablets are indicated for adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Subscribe To Our Newsletter & Stay Updated
